Klaas Financial Asset Advisors, LLC Pfizer Inc Transaction History

Klaas Financial Asset Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $24,138 - $31,008	-615 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $215 - $244	6 Added 0.99%	615 $24,000
Q1 2021 Apr 20, 2021	BUY	$33.49 - $37.77 $234 - $264	7 Added 1.16%	609 $22,000
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $20,148 - $25,621	602 New	602 $22,000

3,340

3.57B

101M

117M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Klaas Financial Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Klaas Financial Asset Advisors, LLC with notifications on news.